SCHEMBL6817845

SCHEMBL6817845

Clc1nc(NCCc2ccccc2)c2ncn(C3CCCC3)c2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.64
CYP2C19 P33261 2/20 0.64
CYP2C9 P11712 1/20 0.64
TSHR P16473 1/20 0.64
CDK1 P06493 6/20 0.62
CTSL P07711 2/20 0.58
ADORA3 P0DMS8 4/20 0.54
ADORA1 P30542 2/20 0.54
ADORA2A P29274 2/20 0.54
FLT3 P36888 2/20 0.53
CCNB2 O95067 1/20 0.53
CCNE2 O96020 1/20 0.53
CDK4 P11802 1/20 0.53
CCNB1 P14635 1/20 0.53
CCND1 P24385 1/20 0.53
CCNE1 P24864 1/20 0.53
CDK2 P24941 1/20 0.53
CCNB3 Q8WWL7 1/20 0.53
NT5E P21589 1/20 0.53
CDK5 Q00535 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6821666 0.94 ADORA3 (0.60) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL8201684 0.93 ADORA3 (0.64) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL6821051 0.93 ADORA3 (0.64) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL6821652 0.89 CTSL (0.52) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL6820861 0.89 CDK1 (0.54) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL5193141 0.89 CDK1 (0.78) CDK1CTSLADORA3ADORA1ADORA2A
SCHEMBL5196991 0.89 CDK1 (0.64) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL6944712 0.88 CDK1 (0.57) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL6945139 0.87 TDP1 (0.65) CYP2D6CYP2C19CYP2C9TSHRCDK1
SCHEMBL6817814 0.86 CDK1 (0.51) CYP2D6CYP2C19CYP2C9TSHRCDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056745-B1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMA INC (US) 2004-06-16 EP disclosed
US-6413974-B1 INHIBITORS OF CYCLIN DEPENDENT KINASES, PARTICULARLY CDK-2; PREVENTING APOPTOSIS IN NEURONAL CELLS; ANTINEOPLASTIC AGENTS; NEURONAL INJURY AND DEGENERATION; CEREBROVASCULAR DISEASE AVENTIS PHARMACEUTICALS INC. 2002-07-02 US disclosed
EP-1056745-A2 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043676-A2 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed